These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 29059363)

  • 1. Consortium on Methods Evaluating Tobacco: Research Tools to Inform US Food and Drug Administration Regulation of Snus.
    Berman ML; Bickel WK; Harris AC; LeSage MG; O'Connor RJ; Stepanov I; Shields PG; Hatsukami DK
    Nicotine Tob Res; 2018 Sep; 20(11):1292-1300. PubMed ID: 29059363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Naturalistic assessment of demand for cigarettes, snus, and nicotine gum.
    Stein JS; Wilson AG; Koffarnus MN; Judd MC; Bickel WK
    Psychopharmacology (Berl); 2017 Jan; 234(2):245-254. PubMed ID: 27730273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations of Proposed Relative-Risk Warning Labels for Snus With Perceptions and Behavioral Intentions Among Tobacco Users and Nonusers.
    Rodu B; Plurphanswat N; Hughes JR; Fagerström K
    Nicotine Tob Res; 2016 May; 18(5):809-16. PubMed ID: 26253616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Harm reduction strategy in tobacco control].
    Gorini G
    Epidemiol Prev; 2011; 35(3-4 Suppl 1):19-32. PubMed ID: 21926451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomised clinical trial of snus versus medicinal nicotine among smokers interested in product switching.
    Hatsukami DK; Severson H; Anderson A; Vogel RI; Jensen J; Broadbent B; Murphy SE; Carmella S; Hecht SS
    Tob Control; 2016 May; 25(3):267-74. PubMed ID: 25991608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No sisyphean task: how the FDA can regulate electronic cigarettes.
    Paradise J
    Yale J Health Policy Law Ethics; 2013; 13(2):326-74. PubMed ID: 24340824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Animal models to assess the abuse liability of tobacco products: effects of smokeless tobacco extracts on intracranial self-stimulation.
    Harris AC; Tally L; Schmidt CE; Muelken P; Stepanov I; Saha S; Vogel RI; LeSage MG
    Drug Alcohol Depend; 2015 Feb; 147():60-7. PubMed ID: 25561387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Research on Youth and Young Adult Tobacco Use, 2013-2018, From the Food and Drug Administration-National Institutes of Health Tobacco Centers of Regulatory Science.
    Perry CL; Creamer MR; Chaffee BW; Unger JB; Sutfin EL; Kong G; Shang C; Clendennen SL; Krishnan-Sarin S; Pentz MA
    Nicotine Tob Res; 2020 Jun; 22(7):1063-1076. PubMed ID: 31127298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Comparison of Dependence across Different Types of Nicotine Containing Products and Coffee.
    Fagerstrom K
    Int J Environ Res Public Health; 2018 Jul; 15(8):. PubMed ID: 30061507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Smokers' Exposure to Perceived Modified Risk Claims for E-Cigarettes, Snus, and Smokeless Tobacco in the United States.
    Wackowski OA; O'Connor RJ; Pearson JL
    Nicotine Tob Res; 2021 Feb; 23(3):605-608. PubMed ID: 32812028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics of "American Snus" and Swedish Snus Products for Sale in Massachusetts, USA.
    Seidenberg AB; Ayo-Yusuf OA; Rees VW
    Nicotine Tob Res; 2018 Jan; 20(2):262-266. PubMed ID: 28003512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reducing tobacco-related harm: FDA's proposed product standard for smokeless tobacco.
    Berman ML; Hatsukami DK
    Tob Control; 2018 May; 27(3):352-354. PubMed ID: 28634163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Impact of Health Warning Labels for Swedish Snus Advertisements on Young Adults' Snus Perceptions and Behavioral Intentions.
    Mays D; Moran MB; Levy DT; Niaura RS
    Nicotine Tob Res; 2016 May; 18(5):1371-5. PubMed ID: 26116085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gender differences in snus versus nicotine gum for cigarette avoidance among a sample of US smokers.
    Allen A; Vogel RI; Meier E; Anderson A; Jensen J; Severson HH; Hatsukami D
    Drug Alcohol Depend; 2016 Nov; 168():8-12. PubMed ID: 27610935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relative Risk Perceptions between Snus and Cigarettes in a Snus-Prevalent Society-An Observational Study over a 16 Year Period.
    Lund KE; Vedoy TF
    Int J Environ Res Public Health; 2019 Mar; 16(5):. PubMed ID: 30862006
    [No Abstract]   [Full Text] [Related]  

  • 16. Interventions to reduce harm from continued tobacco use.
    Lindson-Hawley N; Hartmann-Boyce J; Fanshawe TR; Begh R; Farley A; Lancaster T
    Cochrane Database Syst Rev; 2016 Oct; 10(10):CD005231. PubMed ID: 27734465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perceptions of Snus Among US Adult Smokers Given Free Product.
    Meier E; Burris JL; Wahlquist A; Garrett-Mayer E; Gray KM; Alberg AJ; Cummings KM; Carpenter MJ
    Nicotine Tob Res; 2017 Dec; 20(1):22-29. PubMed ID: 28034999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-Intensity Sweeteners in Alternative Tobacco Products.
    Miao S; Beach ES; Sommer TJ; Zimmerman JB; Jordt SE
    Nicotine Tob Res; 2016 Nov; 18(11):2169-2173. PubMed ID: 27217475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple tobacco product use among US adolescents and young adults.
    Soneji S; Sargent J; Tanski S
    Tob Control; 2016 Mar; 25(2):174-80. PubMed ID: 25361744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of reduced-risk nicotine-delivery products on smoking prevalence and cigarette sales: an observational study.
    Pesola F; Phillips-Waller A; Beard E; Shahab L; Sweanor D; Jarvis M; Hajek P
    Public Health Res (Southampt); 2023 Sep; 11(7):1-39. PubMed ID: 37795840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.